According to GlobalData’s medical device pipeline database, five Minimally Invasive Neurosurgery devices are in various stages of development globally. GlobalData’s report Minimally Invasive Neurosurgery provides an overview of the segment’s pipeline landscape and offers detailed analysis of its products. Buy the report here.

Smarter leaders trust GlobalData

All five devices of this category are in active stage of development. All devices are in the early stages of development.

Neurology devices are designed to diagnose, treat, and monitor conditions that affect the nervous system, including the brain, spinal cord, and peripheral nerves. Minimally invasive neurosurgical devices are used to enable neurosurgery without large incisions into the skull. These devices aim to maximize visualization of cranial tissue while reducing post-operative complications during surgical procedures. Minimally invasive neurosurgical devices comprise disposable handpieces, ultrasonic aspiration disposable tips, and subcortical access devices are tracked under this segment.

Innovations in the medical devices sector are linked to the development of new approaches, processes, or technologies for treating, diagnosing, and managing disease in response to demand from healthcare for better patient outcomes and reduce healthcare costs.

Based on an analysis of GlobalData’s Medical Intelligence Center pipeline product database, these actively developed Minimally Invasive Neurosurgery pipeline devices are all expected to be approved within the next ten years.

Currently, private organizations, public entities and institutions are working on the development of Minimally Invasive Neurosurgery devices. Overall, most of these Minimally Invasive Neurosurgery pipeline devices are being developed by private entities.

Key players involved in the active development of Minimally Invasive Neurosurgery include Imggyd, Indian Institute of Technology Delhi, Medtronic, NeuroOne Medical Technologies and University of Pittsburgh.

For a complete picture of the developmental pipeline for Minimally Invasive Neurosurgery devices, buy the report here.

Data Insights

From

The gold standard of business intelligence.

Blending expert knowledge with cutting-edge technology, GlobalData’s unrivalled proprietary data will enable you to decode what’s happening in your market. You can make better informed decisions and gain a future-proof advantage over your competitors.

GlobalData

GlobalData, the leading provider of industry intelligence, provided the underlying data, research, and analysis used to produce this article. 

The medical devices pipeline data used in this article were obtained from the Medical Pipeline Products Database of GlobalData’s Medical Intelligence Center. The Pipeline Products database is a is a comprehensive source of information on medical devices, it covers 39K products which are in development stage and intended for diagnosis, treatment, and management of diseases/conditions/symptoms directly or indirectly. The pipeline products included in the database are sourced from reliable and authenticated sources, such as company websites, SEC filings, conference presentations, analyst presentations, news releases, clinical trial registries, and grants. The information is collected by following systematic research techniques and proprietary methodology.